Aytu Biopharma Inc

Change company Symbol lookup

Select an option...

AYTU Aytu Biopharma Inc

MDGS Medigus Ltd

WAVD Wavedancer Inc

GTH Genetron Holdings Ltd

NIO NIO Inc

EWA iShares MSCI Australia ETF

WDAY Workday Inc

BNOX Bionomics Ltd

NRDY Nerdy Inc

KEY KeyCorp

Go

Aytu BioPharma, Inc. is a pharmaceutical company. The Company is focused on commercializing therapeutics and consumer health products and developing therapeutics for rare pediatric-onset or difficult-to-treat diseases. It manufactures its products for the treatment of attention deficit hyperactivity disorder (ADHD) at its manufacturing facilities and uses third party manufacturers for its other prescription and consumer health products. The Company operates through two business segments: BioPharma and Consumer Health. The BioPharma segment consists of prescription pharmaceutical products (the Rx Portfolio). The Consumer Health segment consists of various consumer healthcare products (the Consumer Health Portfolio). The Company also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome (VEDS) and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections.